HLOC
CL icon

H.L. Ormond & Company’s Colgate-Palmolive CL Stock Holding History

H.L. Ormond & Company’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$620K Sell
8,830
-128
-1% -$10K 0.99% 50
2022
Q2 		$718K Sell
8,958
-134
-1% -$10.5K 1.16% 38
2022
Q1 		$689K Sell
9,092
-1,295
-12% -$103K 0.84% 58
2021
Q4 		$841K Buy
+10,387
New +$811K 0.99% 46

Other funds holding CL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

H.L. Ormond & Company's CL Position: Q3 2022 in Review

H.L. Ormond & Company reduced its Colgate-Palmolive (CL) stake by 1.4% in Q3 2022, selling an estimated $10K and leaving 8,830 shares worth $620K. The position accounts for 0.99% of the portfolio, ranked #50.

H.L. Ormond & Company first reported a position in CL in Q4 2021 and has held it in 4 quarters since. The position peaked at $841K in Q4 2021. 1,614 funds tracked by Wall St. Rank hold CL as of Q3 2022.

  • H.L. Ormond & Company held 8,830 shares of Colgate-Palmolive worth $620K as of Q3 2022.
  • H.L. Ormond & Company sold 128 Colgate-Palmolive shares in Q3 2022, an estimated $10K.
  • Colgate-Palmolive made up 0.99% of H.L. Ormond & Company's portfolio in Q3 2022, its #50 holding.
  • H.L. Ormond & Company first reported a position in Colgate-Palmolive in Q4 2021 and has held it in 4 quarters since.
  • H.L. Ormond & Company's Colgate-Palmolive position peaked at $841K in Q4 2021.
  • 1,614 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2022.

Based on H.L. Ormond & Company's 13F filing for Q3 2022, filed 14 Nov 2022.